OCUP - Ocuphire Pharma GAAP EPS of -$0.24 beats by $0.03 revenue of $3.67M beats by $1.39M
2023-08-11 08:49:06 ET
- Ocuphire Pharma press release ( NASDAQ: OCUP ): Q2 GAAP EPS of -$0.24 beats by $0.03 .
- Revenue of $3.67M beats by $1.39M .
- As of June 30, 2023, Ocuphire had cash and cash equivalents of approximately $40.0 million. The Company has no debt. Based on current projections, management believes the present cash on hand will be sufficient to fund operations into 2025.
For further details see:
Ocuphire Pharma GAAP EPS of -$0.24 beats by $0.03, revenue of $3.67M beats by $1.39M